Is cimetidine (Cimetidine) effective for treating molluscum contagiosum in a 4-year-old male patient weighing 12.8 kilograms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I do not recommend cimetidine for treating molluscum contagiosum in a 4-year-old boy weighing 12.8 kg. Cimetidine, an H2 receptor antagonist typically used for acid reflux, has been studied for molluscum treatment based on its potential immune-modulating effects, but evidence for its effectiveness is limited and inconsistent 1. For a 4-year-old with molluscum, watchful waiting is often the best approach as these viral lesions typically resolve spontaneously within 6-18 months without treatment. If treatment is desired, first-line options would include gentle curettage or cantharidin application performed by a healthcare provider. Some key points to consider in the management of molluscum contagiosum include:

  • Maintaining good hygiene to prevent spread
  • Avoiding sharing towels or bathwater
  • Covering lesions when possible to reduce the risk of transmission
  • Considering the potential risks and benefits of treatment, including the risk of scarring or postinflammatory hyperpigmentation with certain treatments like cryotherapy 1
  • Recognizing that cimetidine is not approved for use in children under 16 years for any indication, including molluscum contagiosum, and its use in this context would be off-label 1 Given the lack of strong evidence supporting the use of cimetidine for molluscum contagiosum, and the availability of safer, more established approaches, cimetidine should not be used for this purpose in young children without strong clinical evidence and proper medical supervision. In general, the management of molluscum contagiosum should prioritize minimizing morbidity, mortality, and impact on quality of life, and should be guided by the most recent and highest-quality evidence available 1.

From the Research

Cimetidine for Molluscum in a 4-Year-Old Male

Overview of Molluscum Contagiosum

  • Molluscum contagiosum is a common skin infection caused by a pox virus, occurring mainly in children 2, 3.
  • The infection usually resolves within months in people without immune deficiency, but treatment may be preferred for social and cosmetic reasons or to avoid spreading the infection 2, 3.

Treatment Options

  • Various treatments have been used for molluscum contagiosum, but a clear evidence base supporting them is lacking 2, 3.
  • Treatment options include destruction, topical therapy, and oral therapy 4.
  • Oral treatment of molluscum includes cimetidine 4, 5.

Cimetidine as a Treatment Option

  • A study published in 1996 found that oral cimetidine may be of benefit in the management of widespread or facial molluscum contagiosum in immunocompetent children 5.
  • The study used a two-month course of oral cimetidine 40 mg/kg/day and found that all but three children who completed treatment experienced clearance of all lesions 5.
  • However, the evidence for the effectiveness of cimetidine in treating molluscum contagiosum is limited, and more research is needed to confirm its efficacy 2, 3.

Dosage and Administration

  • The dosage of cimetidine used in the 1996 study was 40 mg/kg/day 5.
  • For a 4-year-old male weighing 12.8 kg, the calculated dosage would be approximately 512 mg/day.
  • However, it is essential to consult with a healthcare professional to determine the appropriate dosage and treatment plan for the child.

Safety and Efficacy

  • The 1996 study found no adverse effects in the children treated with cimetidine 5.
  • However, the evidence for the safety and efficacy of cimetidine in treating molluscum contagiosum is limited, and more research is needed to confirm its safety and efficacy 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Interventions for cutaneous molluscum contagiosum.

The Cochrane database of systematic reviews, 2009

Research

Interventions for cutaneous molluscum contagiosum.

The Cochrane database of systematic reviews, 2017

Related Questions

What are the oral treatment options for molluscum contagiosum?
What are the treatment options for molluscum contagiosum?
Can Molluscum contagiosum be treated with oral medication?
What is the efficacy of Cimetidine (cimetidine) treatment for Molluscum contagiosum in the pediatric population?
What are the treatment options for infected Molluscum contagiosum (a viral skin infection)?
What is the most likely diagnosis for a 32-year-old woman presenting with progressive symmetric sensory loss ascending to the umbilicus, urinary urgency, frequency, nocturia, and a tight band-like sensation around her midabdominal region, with examination findings of slowed eye adduction, diffuse hyperreflexia, and decreased sensation to pinprick to the level of the umbilicus?
What is the equivalent intravenous (IV) dose for a patient currently taking 60mg of morphine (opioid analgesic) extended release (ER)?
What is the most likely cause of a 16-year-old girl's transient loss of consciousness, characterized by preceding symptoms of hyperthermia, nausea, diaphoresis, and tinnitus, followed by a brief episode of tremors and loss of postural tone, after which she rapidly regained consciousness?
What is the most likely causal organism in a 3-day-old boy with seizures, lethargy, hypoglycemia (low blood sugar), and cerebrospinal fluid (CSF) analysis showing gram-positive cocci, low glucose, elevated protein, and pleocytosis (increased white blood cell count)?
What is the cost of Fucibet (betamethasone and fusidic acid) in Alberta?
What is CD19 (Cluster of Differentiation 19) a marker for?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.